Mónica Nave
Hospital da Luz(PT)
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, Ovarian cancer diagnosis and treatment, HER2/EGFR in Cancer Research, Breast Cancer Treatment Studies, Endometrial and Cervical Cancer Treatments
Most-Cited Works
- → Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: The DEBBRAH trial(2022)242 cited
- → Screening for a BRCA2 Rearrangement in High-Risk Breast/Ovarian Cancer Families: Evidence for a Founder Effect and Analysis of the Associated Phenotypes(2007)113 cited
- → Prognosis of polymerase epsilon (POLE) mutation in high-grade endometrioid endometrial cancer: Systematic review and meta-analysis(2024)32 cited
- → Chemotherapy-free treatment of recurrent advanced ovarian cancer: myth or reality?(2022)9 cited
- → Sudden death during adjuvant trastuzumab therapy of breast cancer(2010)8 cited
- → Abstract PD7-02: Trastuzumab Deruxtecan in patients with Unstable Central Nervous System Involvement from HER2-Low Advanced Breast Cancer: The DEBBRAH Trial(2023)6 cited
- → Abstract PD4-06: Trastuzumab deruxtecan in patients with HER2[+] or HER2-low-expressing advanced breast cancer and central nervous system involvement: Preliminary results from the DEBBRAH phase 2 study(2022)5 cited
- → 330TiP Trastuzumab deruxtecan (T-DXd; DS-8201) in HER2-positive (HER2+) and HER2-low expressing (HER-LE) metastatic breast cancer (MBC) with brain metastases (BM) and/or leptomeningeal carcinomatosis (LMC): DEBBRAH(2021)4 cited
- → Molecular classification of endometrial cancer: preliminary experience from a single Portuguese academic center(2024)3 cited
- → Loss of HER2 amplification and disease prognosis after neoadjuvant treatment of HER2 amplified breast cancer(2018)2 cited